The BIA has submitted a letter to Guy Opperman MP as part of the Department for Work and Pensions' (DWP) consultation on Broadening the investment opportunities of defined contribution pension schemes.
As we settle into the rhythms of daily life and gather our thoughts about the year ahead, our policy experts have weighed in on what the life sciences sector might expect in 2026.
OutSee, a genomics and drug discovery company pioneering a unique AI-based predictive genomics approach to target discovery, today announced the closure of its £2.5 million seed funding round.
This week JPM kicks off in San Francisco with BIA hosting a UK Reception. A significant week for BIA too with the long-awaited announcement of our new CEO.
Pioneer Group, a specialist in life science infrastructure and venture building, and global biopharmaceutical company AbbVie, have crowned Alceus Bio the winner of their 2025 Golden Ticket programme.
Relation and healthcare investment firm Deerfield Management, a current investor, has launched a new research collaboration to advance therapeutic discovery projects for diseases of high unmet need.
